147 related articles for article (PubMed ID: 32937962)
1. Prospective Study Using Plasma Apolipoprotein A2-Isoforms to Screen for High-Risk Status of Pancreatic Cancer.
Sato Y; Kobayashi T; Nishiumi S; Okada A; Fujita T; Sanuki T; Kobayashi M; Asahara M; Adachi M; Sakai A; Shiomi H; Masuda A; Yoshida M; Takeuchi K; Kodama Y; Kutsumi H; Nagashima K; Honda K
Cancers (Basel); 2020 Sep; 12(9):. PubMed ID: 32937962
[TBL] [Abstract][Full Text] [Related]
2. Clinical development of a blood biomarker using apolipoprotein-A2 isoforms for early detection of pancreatic cancer.
Kashiro A; Kobayashi M; Oh T; Miyamoto M; Atsumi J; Nagashima K; Takeuchi K; Nara S; Hijioka S; Morizane C; Kikuchi S; Kato S; Kato K; Ochiai H; Obata D; Shizume Y; Konishi H; Nomura Y; Matsuyama K; Xie C; Wong C; Huang Y; Jung G; Srivastava S; Kutsumi H; Honda K
J Gastroenterol; 2024 Mar; 59(3):263-278. PubMed ID: 38261000
[TBL] [Abstract][Full Text] [Related]
3. CA19-9 and apolipoprotein-A2 isoforms as detection markers for pancreatic cancer: a prospective evaluation.
Honda K; Katzke VA; Hüsing A; Okaya S; Shoji H; Onidani K; Olsen A; Tjønneland A; Overvad K; Weiderpass E; Vineis P; Muller D; Tsilidis K; Palli D; Pala V; Tumino R; Naccarati A; Panico S; Aleksandrova K; Boeing H; Bueno-de-Mesquita HB; Peeters PH; Trichopoulou A; Lagiou P; Khaw KT; Wareham N; Travis RC; Merino S; Duell EJ; Rodríguez-Barranco M; Chirlaque MD; Barricarte A; Rebours V; Boutron-Ruault MC; Romana Mancini F; Brennan P; Scelo G; Manjer J; Sund M; Öhlund D; Canzian F; Kaaks R
Int J Cancer; 2019 Apr; 144(8):1877-1887. PubMed ID: 30259989
[TBL] [Abstract][Full Text] [Related]
4. Serum apolipoprotein A2 isoforms in autoimmune pancreatitis.
Kobayashi T; Sato Y; Nishiumi S; Yagi Y; Sakai A; Shiomi H; Masuda A; Okaya S; Kutsumi H; Yoshida M; Honda K
Biochem Biophys Res Commun; 2018 Mar; 497(3):903-907. PubMed ID: 29481802
[TBL] [Abstract][Full Text] [Related]
5. Apolipoprotein A2 Isoforms in Relation to the Risk of Myocardial Infarction: A Nested Case-Control Analysis in the JPHC Study.
Kihara T; Yamagishi K; Honda K; Ikeda A; Yatsuya H; Saito I; Kokubo Y; Yamaji T; Shimazu T; Sawada N; Iwasaki M; Iso H; Tsugane S;
J Atheroscler Thromb; 2021 May; 28(5):483-490. PubMed ID: 32863295
[TBL] [Abstract][Full Text] [Related]
6. Risk stratification of pancreatic cancer by a blood test for apolipoprotein A2-isoforms.
Honda K
Cancer Biomark; 2022; 33(4):503-512. PubMed ID: 35491769
[TBL] [Abstract][Full Text] [Related]
7. Apolipoprotein A2 isoforms associated with exocrine pancreatic insufficiency in early chronic pancreatitis.
Futagami S; Agawa S; Nakamura K; Watanabe Y; Habiro M; Kawawa R; Yamawaki H; Tsushima R; Kirita K; Akimoto T; Ueki N; Tomohide T; Itokawa N; Suzuki N; Naito Y; Takeuchi K; Kashiro A; Ohta R; Mizutani S; Taniai N; Yoshida H; Iwakiri K; Honda K
J Gastroenterol Hepatol; 2023 Nov; 38(11):1949-1957. PubMed ID: 37501507
[TBL] [Abstract][Full Text] [Related]
8. Plasma biomarker for detection of early stage pancreatic cancer and risk factors for pancreatic malignancy using antibodies for apolipoprotein-AII isoforms.
Honda K; Kobayashi M; Okusaka T; Rinaudo JA; Huang Y; Marsh T; Sanada M; Sasajima Y; Nakamori S; Shimahara M; Ueno T; Tsuchida A; Sata N; Ioka T; Yasunami Y; Kosuge T; Miura N; Kamita M; Sakamoto T; Shoji H; Jung G; Srivastava S; Yamada T
Sci Rep; 2015 Nov; 5():15921. PubMed ID: 26549697
[TBL] [Abstract][Full Text] [Related]
9. Systematic review of the utility of 18-FDG PET in the preoperative evaluation of IPMNs and cystic lesions of the pancreas.
Srinivasan N; Koh YX; Goh BKP
Surgery; 2019 May; 165(5):929-937. PubMed ID: 30577952
[TBL] [Abstract][Full Text] [Related]
10. Potential usefulness of apolipoprotein A2 isoforms for screening and risk stratification of pancreatic cancer.
Honda K; Srivastava S
Biomark Med; 2016 Nov; 10(11):1197-1207. PubMed ID: 27673558
[TBL] [Abstract][Full Text] [Related]
11. Characteristics and Clinical Outcomes of Individuals at High Risk for Pancreatic Cancer: A Descriptive Analysis from a Comprehensive Cancer Center.
McNamara GPJ; Ali KN; Vyas S; Huynh T; Nyland M; Almanza D; Laronga C; Klapman J; Permuth JB
Gastrointest Disord (Basel); 2019 Mar; 1(1):106-119. PubMed ID: 32601617
[TBL] [Abstract][Full Text] [Related]
12. Natural history of intraductal papillary mucinous neoplasm and non-neoplastic cyst: long-term imaging follow-up study.
Hisada Y; Nagata N; Imbe K; Takasaki Y; Sekine K; Tajima T; Yanase M; Fujimoto K; Akiyama J; Uemura N
J Hepatobiliary Pancreat Sci; 2017 Jul; 24(7):401-408. PubMed ID: 28512773
[TBL] [Abstract][Full Text] [Related]
13. High-Grade Dysplasia in Resected Main-Duct Intraductal Papillary Mucinous Neoplasm (MD-IPMN) is Associated with an Increased Risk of Subsequent Pancreatic Cancer.
Majumder S; Philip NA; Singh Nagpal SJ; Takahashi N; Mara KC; Kendrick ML; Smyrk TC; Zhang L; Levy MJ; Gleeson FC; Petersen BT; Pearson RK; Topazian MD; Vege SS; Chari ST
Am J Gastroenterol; 2019 Mar; 114(3):524-529. PubMed ID: 30413822
[TBL] [Abstract][Full Text] [Related]
14. Natural history of pancreatic cystic lesions: A multicenter prospective observational study for evaluating the risk of pancreatic cancer.
Ohno E; Hirooka Y; Kawashima H; Ishikawa T; Kanamori A; Ishikawa H; Sasaki Y; Nonogaki K; Hara K; Hashimoto S; Matsubara H; Hirai T; Sumi H; Sugimoto H; Goto H;
J Gastroenterol Hepatol; 2018 Jan; 33(1):320-328. PubMed ID: 28872701
[TBL] [Abstract][Full Text] [Related]
15. Screening for Pancreatic Cancer.
Ngamruengphong S; Canto MI
Surg Clin North Am; 2016 Dec; 96(6):1223-1233. PubMed ID: 27865274
[TBL] [Abstract][Full Text] [Related]
16. Five years of prospective screening of high-risk individuals from families with familial pancreatic cancer.
Langer P; Kann PH; Fendrich V; Habbe N; Schneider M; Sina M; Slater EP; Heverhagen JT; Gress TM; Rothmund M; Bartsch DK
Gut; 2009 Oct; 58(10):1410-8. PubMed ID: 19470496
[TBL] [Abstract][Full Text] [Related]
17. New strategies for the early detection of pancreatic cancer.
Petrone MC; Arcidiacono PG
Expert Rev Gastroenterol Hepatol; 2016; 10(2):157-9. PubMed ID: 26582179
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the Sendai and 2012 International Consensus Guidelines based on cross-sectional imaging findings performed for the initial triage of mucinous cystic lesions of the pancreas: a single institution experience with 114 surgically treated patients.
Goh BK; Thng CH; Tan DM; Low AS; Wong JS; Cheow PC; Chow PK; Chung AY; Wong WK; Ooi LL
Am J Surg; 2014 Aug; 208(2):202-9. PubMed ID: 24530043
[TBL] [Abstract][Full Text] [Related]
19. Pancreatic cancer screening: Still a delusion?
Moutinho-Ribeiro P; Coelho R; Giovannini M; Macedo G
Pancreatology; 2017; 17(5):754-765. PubMed ID: 28739291
[TBL] [Abstract][Full Text] [Related]
20. Circulating lncRNA ABHD11-AS1 serves as a biomarker for early pancreatic cancer diagnosis.
Liu Y; Feng W; Liu W; Kong X; Li L; He J; Wang D; Zhang M; Zhou G; Xu W; Chen W; Gong A; Xu M
J Cancer; 2019; 10(16):3746-3756. PubMed ID: 31333792
[No Abstract] [Full Text] [Related]
[Next] [New Search]
